Poly(lactic acid)-based particulate systems are promising tools for immune modulation
[Display omitted] Poly(lactic acid) (PLA) is one of the most successful and versatile polymers explored for controlled delivery of bioactive molecules. Its attractive properties of biodegradability and biocompatibility in vivo have contributed in a meaningful way to the approval of different product...
Gespeichert in:
Veröffentlicht in: | Acta biomaterialia 2017-01, Vol.48, p.41-57 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 57 |
---|---|
container_issue | |
container_start_page | 41 |
container_title | Acta biomaterialia |
container_volume | 48 |
creator | Peres, Carina Matos, Ana I. Conniot, João Sainz, Vanessa Zupančič, Eva Silva, Joana M. Graça, Luís Sá Gaspar, Rogério Préat, Véronique Florindo, Helena F. |
description | [Display omitted]
Poly(lactic acid) (PLA) is one of the most successful and versatile polymers explored for controlled delivery of bioactive molecules. Its attractive properties of biodegradability and biocompatibility in vivo have contributed in a meaningful way to the approval of different products by the FDA and EMA for a wide range of biomedical and pharmaceutical applications, in the past two decades. This polymer has been widely used for the preparation of particles as delivery systems of several therapeutic molecules, including vaccines. These PLA vaccine carriers have shown to induce a sustained and targeted release of different bacterial, viral and tumor-associated antigens and adjuvants in vivo, triggering distinct immune responses. The present review intends to highlight and discuss the major advantages of PLA as a promising polymer for the development of potent vaccine delivery systems against pathogens and cancer. It aims to provide a critical discussion based on preclinical data to better understand the major effect of PLA-based carrier properties on their interaction with immune cells and thus their role in the modulation of host immunity.
During the last decades, vaccination has had a great impact on global health with the control of many severe diseases. Polymeric nanosystems have emerged as promising strategies to stabilize vaccine antigens, promoting their controlled release to phagocytic cells, thus avoiding the need for multiple administrations. One of the most promising polymers are the aliphatic polyesters, which include the poly(lactic acid). This is a highly versatile biodegradable and biocompatible polymer. Products containing this polymer have already been approved for all food and some biomedical applications. Despite all favorable characteristics presented above, PLA has been less intensively discussed than other polymers, such as its copolymer PLGA, including regarding its application in vaccination and particularly in tumor immunotherapy. The present review discusses the major advantages of poly(lactic acid) for the development of potent vaccine delivery systems, providing a critical view on the main properties that determine their effect on the modulation of immune cells. |
doi_str_mv | 10.1016/j.actbio.2016.11.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1839107891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1742706116305992</els_id><sourcerecordid>1916141585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-1796262c421b8fd8ea5325351bfe603e4b09b5e51ac14fa5d30d7211ec2be4433</originalsourceid><addsrcrecordid>eNp9kMFq3DAURUVISSZp_6AEQTaThV09ybLlTSEMSVsItItmLWTpuWiwrYlkF-bvo2EmWXTRlfTEeVeXQ8hnYCUwqL9sS2PnzoeS56kEKBnwM7IC1aiikbU6z_em4kXDargkVyltGRMKuLogl7xRvM7jijz_CsN-PeQob6mx3t0VnUno6M7E_LQMZkaa9mnGMVETke5iGH3y0x86hzAk2odI_TguE9IxuAPvw_SRfOjNkPDT6bwmz48Pvzffi6ef335s7p8KK1o2F9C0Na-5rTh0qncKjRRcCgldjzUTWHWs7SRKMBaq3kgnmGs4AFreYVUJcU3Wx9zc6mXBNOvczeIwmAnDkjQo0QJrVAsZvf0H3YYlTrmdhhZqqEAqmanqSNkYUorY6130o4l7DUwftOutPmrXB-0aQGftee3mFL50I7r3pTfPGfh6BDDb-Osx6mQ9Thadj2hn7YL__w-vi4qUuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1916141585</pqid></control><display><type>article</type><title>Poly(lactic acid)-based particulate systems are promising tools for immune modulation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Peres, Carina ; Matos, Ana I. ; Conniot, João ; Sainz, Vanessa ; Zupančič, Eva ; Silva, Joana M. ; Graça, Luís ; Sá Gaspar, Rogério ; Préat, Véronique ; Florindo, Helena F.</creator><creatorcontrib>Peres, Carina ; Matos, Ana I. ; Conniot, João ; Sainz, Vanessa ; Zupančič, Eva ; Silva, Joana M. ; Graça, Luís ; Sá Gaspar, Rogério ; Préat, Véronique ; Florindo, Helena F.</creatorcontrib><description>[Display omitted]
Poly(lactic acid) (PLA) is one of the most successful and versatile polymers explored for controlled delivery of bioactive molecules. Its attractive properties of biodegradability and biocompatibility in vivo have contributed in a meaningful way to the approval of different products by the FDA and EMA for a wide range of biomedical and pharmaceutical applications, in the past two decades. This polymer has been widely used for the preparation of particles as delivery systems of several therapeutic molecules, including vaccines. These PLA vaccine carriers have shown to induce a sustained and targeted release of different bacterial, viral and tumor-associated antigens and adjuvants in vivo, triggering distinct immune responses. The present review intends to highlight and discuss the major advantages of PLA as a promising polymer for the development of potent vaccine delivery systems against pathogens and cancer. It aims to provide a critical discussion based on preclinical data to better understand the major effect of PLA-based carrier properties on their interaction with immune cells and thus their role in the modulation of host immunity.
During the last decades, vaccination has had a great impact on global health with the control of many severe diseases. Polymeric nanosystems have emerged as promising strategies to stabilize vaccine antigens, promoting their controlled release to phagocytic cells, thus avoiding the need for multiple administrations. One of the most promising polymers are the aliphatic polyesters, which include the poly(lactic acid). This is a highly versatile biodegradable and biocompatible polymer. Products containing this polymer have already been approved for all food and some biomedical applications. Despite all favorable characteristics presented above, PLA has been less intensively discussed than other polymers, such as its copolymer PLGA, including regarding its application in vaccination and particularly in tumor immunotherapy. The present review discusses the major advantages of poly(lactic acid) for the development of potent vaccine delivery systems, providing a critical view on the main properties that determine their effect on the modulation of immune cells.</description><identifier>ISSN: 1742-7061</identifier><identifier>EISSN: 1878-7568</identifier><identifier>DOI: 10.1016/j.actbio.2016.11.012</identifier><identifier>PMID: 27826003</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adjuvant ; Adjuvants ; Aliphatic compounds ; Animals ; Antigen (tumor-associated) ; Antigens ; Bacteria ; Biocompatibility ; Biodegradability ; Biodegradation ; Biomedical materials ; Cancer ; Controlled release ; Data processing ; Drug delivery systems ; Global health ; Humans ; Immune modulation ; Immune response ; Immune system ; Immunity ; Immunity - drug effects ; Immunomodulation ; Immunomodulation - drug effects ; Immunotherapy ; Microparticles ; Modulation ; Nanoparticles ; Nanoparticles - chemistry ; Nanotechnology ; Particulates ; Pathogens ; Phagocytes ; Poly(lactic acid) ; Polyester resins ; Polyesters ; Polyesters - pharmacology ; Polylactic acid ; Polylactide-co-glycolide ; Polymers ; Properties (attributes) ; Surgical implants ; Vaccine ; Vaccines ; Vaccines - administration & dosage</subject><ispartof>Acta biomaterialia, 2017-01, Vol.48, p.41-57</ispartof><rights>2016 Acta Materialia Inc.</rights><rights>Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier BV Jan 15, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-1796262c421b8fd8ea5325351bfe603e4b09b5e51ac14fa5d30d7211ec2be4433</citedby><cites>FETCH-LOGICAL-c390t-1796262c421b8fd8ea5325351bfe603e4b09b5e51ac14fa5d30d7211ec2be4433</cites><orcidid>0000-0002-3111-8744</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1742706116305992$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27826003$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peres, Carina</creatorcontrib><creatorcontrib>Matos, Ana I.</creatorcontrib><creatorcontrib>Conniot, João</creatorcontrib><creatorcontrib>Sainz, Vanessa</creatorcontrib><creatorcontrib>Zupančič, Eva</creatorcontrib><creatorcontrib>Silva, Joana M.</creatorcontrib><creatorcontrib>Graça, Luís</creatorcontrib><creatorcontrib>Sá Gaspar, Rogério</creatorcontrib><creatorcontrib>Préat, Véronique</creatorcontrib><creatorcontrib>Florindo, Helena F.</creatorcontrib><title>Poly(lactic acid)-based particulate systems are promising tools for immune modulation</title><title>Acta biomaterialia</title><addtitle>Acta Biomater</addtitle><description>[Display omitted]
Poly(lactic acid) (PLA) is one of the most successful and versatile polymers explored for controlled delivery of bioactive molecules. Its attractive properties of biodegradability and biocompatibility in vivo have contributed in a meaningful way to the approval of different products by the FDA and EMA for a wide range of biomedical and pharmaceutical applications, in the past two decades. This polymer has been widely used for the preparation of particles as delivery systems of several therapeutic molecules, including vaccines. These PLA vaccine carriers have shown to induce a sustained and targeted release of different bacterial, viral and tumor-associated antigens and adjuvants in vivo, triggering distinct immune responses. The present review intends to highlight and discuss the major advantages of PLA as a promising polymer for the development of potent vaccine delivery systems against pathogens and cancer. It aims to provide a critical discussion based on preclinical data to better understand the major effect of PLA-based carrier properties on their interaction with immune cells and thus their role in the modulation of host immunity.
During the last decades, vaccination has had a great impact on global health with the control of many severe diseases. Polymeric nanosystems have emerged as promising strategies to stabilize vaccine antigens, promoting their controlled release to phagocytic cells, thus avoiding the need for multiple administrations. One of the most promising polymers are the aliphatic polyesters, which include the poly(lactic acid). This is a highly versatile biodegradable and biocompatible polymer. Products containing this polymer have already been approved for all food and some biomedical applications. Despite all favorable characteristics presented above, PLA has been less intensively discussed than other polymers, such as its copolymer PLGA, including regarding its application in vaccination and particularly in tumor immunotherapy. The present review discusses the major advantages of poly(lactic acid) for the development of potent vaccine delivery systems, providing a critical view on the main properties that determine their effect on the modulation of immune cells.</description><subject>Adjuvant</subject><subject>Adjuvants</subject><subject>Aliphatic compounds</subject><subject>Animals</subject><subject>Antigen (tumor-associated)</subject><subject>Antigens</subject><subject>Bacteria</subject><subject>Biocompatibility</subject><subject>Biodegradability</subject><subject>Biodegradation</subject><subject>Biomedical materials</subject><subject>Cancer</subject><subject>Controlled release</subject><subject>Data processing</subject><subject>Drug delivery systems</subject><subject>Global health</subject><subject>Humans</subject><subject>Immune modulation</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunity - drug effects</subject><subject>Immunomodulation</subject><subject>Immunomodulation - drug effects</subject><subject>Immunotherapy</subject><subject>Microparticles</subject><subject>Modulation</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Nanotechnology</subject><subject>Particulates</subject><subject>Pathogens</subject><subject>Phagocytes</subject><subject>Poly(lactic acid)</subject><subject>Polyester resins</subject><subject>Polyesters</subject><subject>Polyesters - pharmacology</subject><subject>Polylactic acid</subject><subject>Polylactide-co-glycolide</subject><subject>Polymers</subject><subject>Properties (attributes)</subject><subject>Surgical implants</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Vaccines - administration & dosage</subject><issn>1742-7061</issn><issn>1878-7568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFq3DAURUVISSZp_6AEQTaThV09ybLlTSEMSVsItItmLWTpuWiwrYlkF-bvo2EmWXTRlfTEeVeXQ8hnYCUwqL9sS2PnzoeS56kEKBnwM7IC1aiikbU6z_em4kXDargkVyltGRMKuLogl7xRvM7jijz_CsN-PeQob6mx3t0VnUno6M7E_LQMZkaa9mnGMVETke5iGH3y0x86hzAk2odI_TguE9IxuAPvw_SRfOjNkPDT6bwmz48Pvzffi6ef335s7p8KK1o2F9C0Na-5rTh0qncKjRRcCgldjzUTWHWs7SRKMBaq3kgnmGs4AFreYVUJcU3Wx9zc6mXBNOvczeIwmAnDkjQo0QJrVAsZvf0H3YYlTrmdhhZqqEAqmanqSNkYUorY6130o4l7DUwftOutPmrXB-0aQGftee3mFL50I7r3pTfPGfh6BDDb-Osx6mQ9Thadj2hn7YL__w-vi4qUuw</recordid><startdate>20170115</startdate><enddate>20170115</enddate><creator>Peres, Carina</creator><creator>Matos, Ana I.</creator><creator>Conniot, João</creator><creator>Sainz, Vanessa</creator><creator>Zupančič, Eva</creator><creator>Silva, Joana M.</creator><creator>Graça, Luís</creator><creator>Sá Gaspar, Rogério</creator><creator>Préat, Véronique</creator><creator>Florindo, Helena F.</creator><general>Elsevier Ltd</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3111-8744</orcidid></search><sort><creationdate>20170115</creationdate><title>Poly(lactic acid)-based particulate systems are promising tools for immune modulation</title><author>Peres, Carina ; Matos, Ana I. ; Conniot, João ; Sainz, Vanessa ; Zupančič, Eva ; Silva, Joana M. ; Graça, Luís ; Sá Gaspar, Rogério ; Préat, Véronique ; Florindo, Helena F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-1796262c421b8fd8ea5325351bfe603e4b09b5e51ac14fa5d30d7211ec2be4433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adjuvant</topic><topic>Adjuvants</topic><topic>Aliphatic compounds</topic><topic>Animals</topic><topic>Antigen (tumor-associated)</topic><topic>Antigens</topic><topic>Bacteria</topic><topic>Biocompatibility</topic><topic>Biodegradability</topic><topic>Biodegradation</topic><topic>Biomedical materials</topic><topic>Cancer</topic><topic>Controlled release</topic><topic>Data processing</topic><topic>Drug delivery systems</topic><topic>Global health</topic><topic>Humans</topic><topic>Immune modulation</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunity - drug effects</topic><topic>Immunomodulation</topic><topic>Immunomodulation - drug effects</topic><topic>Immunotherapy</topic><topic>Microparticles</topic><topic>Modulation</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Nanotechnology</topic><topic>Particulates</topic><topic>Pathogens</topic><topic>Phagocytes</topic><topic>Poly(lactic acid)</topic><topic>Polyester resins</topic><topic>Polyesters</topic><topic>Polyesters - pharmacology</topic><topic>Polylactic acid</topic><topic>Polylactide-co-glycolide</topic><topic>Polymers</topic><topic>Properties (attributes)</topic><topic>Surgical implants</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Vaccines - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peres, Carina</creatorcontrib><creatorcontrib>Matos, Ana I.</creatorcontrib><creatorcontrib>Conniot, João</creatorcontrib><creatorcontrib>Sainz, Vanessa</creatorcontrib><creatorcontrib>Zupančič, Eva</creatorcontrib><creatorcontrib>Silva, Joana M.</creatorcontrib><creatorcontrib>Graça, Luís</creatorcontrib><creatorcontrib>Sá Gaspar, Rogério</creatorcontrib><creatorcontrib>Préat, Véronique</creatorcontrib><creatorcontrib>Florindo, Helena F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Acta biomaterialia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peres, Carina</au><au>Matos, Ana I.</au><au>Conniot, João</au><au>Sainz, Vanessa</au><au>Zupančič, Eva</au><au>Silva, Joana M.</au><au>Graça, Luís</au><au>Sá Gaspar, Rogério</au><au>Préat, Véronique</au><au>Florindo, Helena F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Poly(lactic acid)-based particulate systems are promising tools for immune modulation</atitle><jtitle>Acta biomaterialia</jtitle><addtitle>Acta Biomater</addtitle><date>2017-01-15</date><risdate>2017</risdate><volume>48</volume><spage>41</spage><epage>57</epage><pages>41-57</pages><issn>1742-7061</issn><eissn>1878-7568</eissn><abstract>[Display omitted]
Poly(lactic acid) (PLA) is one of the most successful and versatile polymers explored for controlled delivery of bioactive molecules. Its attractive properties of biodegradability and biocompatibility in vivo have contributed in a meaningful way to the approval of different products by the FDA and EMA for a wide range of biomedical and pharmaceutical applications, in the past two decades. This polymer has been widely used for the preparation of particles as delivery systems of several therapeutic molecules, including vaccines. These PLA vaccine carriers have shown to induce a sustained and targeted release of different bacterial, viral and tumor-associated antigens and adjuvants in vivo, triggering distinct immune responses. The present review intends to highlight and discuss the major advantages of PLA as a promising polymer for the development of potent vaccine delivery systems against pathogens and cancer. It aims to provide a critical discussion based on preclinical data to better understand the major effect of PLA-based carrier properties on their interaction with immune cells and thus their role in the modulation of host immunity.
During the last decades, vaccination has had a great impact on global health with the control of many severe diseases. Polymeric nanosystems have emerged as promising strategies to stabilize vaccine antigens, promoting their controlled release to phagocytic cells, thus avoiding the need for multiple administrations. One of the most promising polymers are the aliphatic polyesters, which include the poly(lactic acid). This is a highly versatile biodegradable and biocompatible polymer. Products containing this polymer have already been approved for all food and some biomedical applications. Despite all favorable characteristics presented above, PLA has been less intensively discussed than other polymers, such as its copolymer PLGA, including regarding its application in vaccination and particularly in tumor immunotherapy. The present review discusses the major advantages of poly(lactic acid) for the development of potent vaccine delivery systems, providing a critical view on the main properties that determine their effect on the modulation of immune cells.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27826003</pmid><doi>10.1016/j.actbio.2016.11.012</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-3111-8744</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-7061 |
ispartof | Acta biomaterialia, 2017-01, Vol.48, p.41-57 |
issn | 1742-7061 1878-7568 |
language | eng |
recordid | cdi_proquest_miscellaneous_1839107891 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adjuvant Adjuvants Aliphatic compounds Animals Antigen (tumor-associated) Antigens Bacteria Biocompatibility Biodegradability Biodegradation Biomedical materials Cancer Controlled release Data processing Drug delivery systems Global health Humans Immune modulation Immune response Immune system Immunity Immunity - drug effects Immunomodulation Immunomodulation - drug effects Immunotherapy Microparticles Modulation Nanoparticles Nanoparticles - chemistry Nanotechnology Particulates Pathogens Phagocytes Poly(lactic acid) Polyester resins Polyesters Polyesters - pharmacology Polylactic acid Polylactide-co-glycolide Polymers Properties (attributes) Surgical implants Vaccine Vaccines Vaccines - administration & dosage |
title | Poly(lactic acid)-based particulate systems are promising tools for immune modulation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Poly(lactic%20acid)-based%20particulate%20systems%20are%20promising%20tools%20for%20immune%20modulation&rft.jtitle=Acta%20biomaterialia&rft.au=Peres,%20Carina&rft.date=2017-01-15&rft.volume=48&rft.spage=41&rft.epage=57&rft.pages=41-57&rft.issn=1742-7061&rft.eissn=1878-7568&rft_id=info:doi/10.1016/j.actbio.2016.11.012&rft_dat=%3Cproquest_cross%3E1916141585%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1916141585&rft_id=info:pmid/27826003&rft_els_id=S1742706116305992&rfr_iscdi=true |